| Biomarker ID | 1130 |
| PMID | 23737455 |
| Year | 2013 |
| Biomarker | Glycerophosphoethanol-amine |
| Biomarker Basis | Concentration Based |
| Biomolecule | Metabolites |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Upregulated in Prostate Cancer |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Malignant Vs Non Malignant |
| Type of Biomarker | Diagnostic |
| Cohort | Matched malignant and nonmalignant prostatectomy samples from 95 PCa patients were taken for the study |
| Senstivity | 61% |
| Specificity | 75% |
| AUC | 0.76 (95% CI: 0.69–0.83) |
| Accuracy | 68% |
| Level Of Significance | p<0.0001 |
| Method Used | gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS/MS) analysis |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |